Prostate Cancer Vaccine

The FDA recently endorsed Provenge, a prostate cancer vaccine, that has proven to be therapuetic and able to extend the lives of the patients that are no longer responding to hormone treatment. Provenge sould be the beginning of many new therapies that are designed to stimulate a patient's own immune system against cancer, according to Dendreon the company that has designed the vaccine. It is also customizable to patients, as doctors will take cells from the patients blood, then add the vaccine and give soultion back to the patient. Provenge will allow the body to recognize prostate cancer cells and lengthen lives of the men inflicted with the disease.

http://health.aol.com/news/story/_a/fda-approves-prostate-cancer-vaccine/n20070329181309990016?cid=474